Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 32%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–33 of 33 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00254423	Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia	completed	Phase 2	150	M.D. Anderson Cancer CenterOTHER	1	Jan 15, 2026	clinicaltrials
NCT00719888	Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease	completed	Phase 2	135	Fred Hutchinson Cancer CenterOTHER	1	Mar 7, 2025	clinicaltrials